Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 19, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
731,205
Total Value
$16,078,267.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 43,735 | $26.88 | $1,175,596.80 | 476,621 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 200,000 | $8.93 | $1,786,000.00 | 676,621 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 15, 2026 | Sale | 128,065 | $52.97 | $6,783,244.47 | 548,556 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 15, 2026 | Sale | 37,270 | $54.20 | $2,020,022.82 | 511,286 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 15, 2026 | Sale | 78,400 | $55.02 | $4,313,403.36 | 432,886 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 43,735 | $0.00 | $0.00 | 168,925 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 200,000 | $0.00 | $0.00 | 160,000 | Direct | โ | View Details |